MDMA Opposes Any Health Reform Device Fee, Even A Reduced One
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Manufacturers Association says it is opposed to any targeted medical device tax in health reform legislation, and would not support even a reduced version of the $4-billion-per-year fee currently proposed in the Senate Finance Committee's bill
You may also be interested in...
With Device Tax Seeming Inevitable, Groups Align On Small-Firm Protections
Groups representing the device industry have aligned to push an amendment to the Senate health care reform bill to exempt more pre- and low-profit companies from the proposed $20 billion device tax
With Device Tax Seeming Inevitable, Groups Align On Small-Firm Protections
Groups representing the device industry have aligned to push an amendment to the Senate health care reform bill to exempt more pre- and low-profit companies from the proposed $20 billion device tax
St. Jude's Departure From AdvaMed Highlights Inherent Industry Tensions
St. Jude Medical CEO Daniel Starks has resigned from AdvaMed's board of directors and the company has left the organization, citing "strong dissent" over how to respond to proposed medical device fees in pending health reform legislation
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: